EML4-ALK V3 drives cell migration through NEK9 and NEK7 kinases in non-small-cell lung cancer
L. O'Regan, G. Barone, R. Adib, C. G. Woo, H. J. Jeong, E. Richardson, M. Richards, P. Muller, S. Collis, D. Fennell, J. Choi, R. Bayliss, A. M. Fry
The paper shows EML4-ALK V3 promotes cell migration via NEK9 and NEK7 kinases, leading to worse outcomes in lung cancer.
bioRxiv · Mar 4, 2019 · PreprintCancer Biology